Heparin flushing and other interventions to maintain patency of central venous catheters: A systematic review

Journal of Advanced Nursing

Volumn 65, Issue 10, 2009, Pages 2007-2021

  Mitchell, Matthew D ^a   Anderson, Barbara Jo ^b   Williams, Kendal ^a,c   Umscheid, Craig A ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Central venous catheters; Heparin flushing; Interventions; Nursing; Patency; Systematic review

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; SODIUM CHLORIDE; UROKINASE;

ADULT; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CHEMICALLY INDUCED DISORDER; CHILD; EQUIPMENT; EVIDENCE BASED PRACTICE; HUMAN; INFANT; INSTRUMENTATION; INTRAARTERIAL DRUG ADMINISTRATION; METHODOLOGY; NURSING RESEARCH; PRACTICE GUIDELINE; PRESCHOOL CHILD; REVIEW; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; EQUIPMENT FAILURE; EVIDENCE-BASED PRACTICE; HEPARIN; HUMANS; INFANT; INFUSIONS, INTRA-ARTERIAL; NURSING RESEARCH; PRACTICE GUIDELINES AS TOPIC; SODIUM CHLORIDE; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 70349093989     PISSN: 03092402     EISSN: 13652648     Source Type: Journal    
DOI: 10.1111/j.1365-2648.2009.05103.x     Document Type: Review

References (49)

1. Abdelkefi A., Ben Othman T., Kammoun L., Chelli M., Ben Romdhane N., Kriaa A., Ladeb S., Torjman L., Lakhal A., Achour W., Hassen A., Hsairi M., Ladeb F. Ben. Abdeladhim A. (2004) Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial. Thrombosis and Haemostasis 92 (3 654 661.
2. Abdelkefi A., Torjman L., Ladeb S., Ben Othman T., Achour W., Lakhal A., Hsairi M., Kammoun L., Ben Hassen A. Ben Abdeladhim A. (2005) Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. Journal of Clinical Oncology 23 (31 7864 7870.
3. Abdelkefi A., Achour W., Ben Othman T., Ladeb S., Torjman L., Lakhal A., Ben Hassen A., Hsairi M. Ben Abdeladhim A. (2007) Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. The Journal of Supportive Oncology 5 (6 273 278.
4. Andersen K.M. Holland J.S. (1992) Maintaining the patency of peripherally inserted central catheters with 10 units/cc heparin. Journal of Intravenous Nursing 15 (2 84 88.
5. Appelgren P., Ransjo U., Bindslev L., Espersen F. Larm O. (1996) Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Critical Care Medicine 24 (9 1482 1489.
6. Bennegard K., Curelaru I., Gustavsson B., Linder L.E. Zachrisson B.F. (1982) Material thrombogenicity in central venous catheterization. I. A comparison between uncoated and heparin-coated, long antebrachial, polyethylene catheters. Acta Anaesthesiologica Scandinavica 26 (2 112 120.
7. Bishop L., Dougherty L., Bodenham A., Mansi J., Crowe P., Kibbler C., Shannon M. Treleaven J. (2007) Guidelines on the insertion and management of central venous access devices in adults. International Journal of Laboratory Hematology 29 (4 261 278.
8. Bowers L., Speroni K.G., Jones L. Atherton M. (2008) Comparison of occlusion rates by flushing solutions for peripherally inserted central catheters with positive pressure luer-activated devices. Journal of Infusion Nursing 31 (1 22 27.
9. Brown-Smith J.K., Stoner M.H. Barley Z.A. (1990) Tunneled catheter thrombosis: factors related to incidence. Oncology Nursing Forum 17 (4 543 549.
10. Buswell L. Beyea S.C. (1998) Flushing protocols for tunneled central venous catheters: an integrative review of the literature. Online Journal of Knowledge Synthesis for Nursing 5 (3 28 36.
11. Carrasco M.N., Bueno A., de las Cuevas C., Jimenez S., Salinas I., Sartorius A., Recio T., Generelo M. Ruiz-Ocaña F. (2004) Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Medicine 30 (4 633 638.
12. Chalmers T.C., Smith H. Jr., Blackburn B., Silverman B., Schroeder B., Reitman D. Ambroz A. (1981) A method for assessing the quality of a randomized control trial. Controlled Clinical Trials 2 (1 31 49.
13. Chan A., Iannucci A. Dager W.E. (2007) Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients. The Annals of Pharmacotherapy 41 (4 635 641.
14. Delva R., Gamelin E., Lortholary A., Maillart P., Leynia de la Jarrige P., Girault C., Guérin J. Larra F. (1998) Suppression of heparinization of central venous catheters between cycles of chemotherapy. Results of a phase I study. Supportive Care in Cancer 6 (4 384 388.
15. Efsing H.O., Lindblad B., Mark J. Wolff T. (1983) Thromboembolic complications from central venous catheters: a comparison of three catheter materials. World Journal of Surgery 7 (3 419 423.
16. Fuentes i Pumarola C., Casademont Mercader R., Colomer Plana M., Cordón Bueno C., Sabench Casellas S., Félez Vidal M. Rodríguez Plazas E. (2007) Comparative study of maintenance of patency of triple lumen central venous catheter. Enfermería Intensiva 18 (1 25 35.
17. Gettings E.M., Brush K.A., Van Cott E.M. Hurford W.E. (2006) Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study. Critical Care (London, England) 10 (6 R161.
18. GRADE Working Group (2004) Grading quality of evidence and strength of recommendations. BMJ 328 (7454) 1490.
19. Hoffer E.K., Borsa J., Santulli P., Bloch R. Fontaine A.B. (1999) Prospective randomized comparison of valved versus nonvalved peripherally inserted central vein catheters. AJR. American Journal of Roentgenology 173 (5 1393 1398.
20. Horne M.K., McCloskey D.J., Calis K., Wesley R., Childs R. Kasten-Sportes C. (2006) Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devices. Pharmacotherapy 26 (9 1262 1267.
21. Infusion Nurses Society (2006) Infusion Nursing Standards of Practice. Journal of Infusion Nursing: The Official Publication of the Infusion Nurses Society 29 (Suppl. 1 S1 S92.
22. Jacobs B.R., Schilling S., Doellman D., Hutchinson N., Rickey M. Nelson S. (2004) Central venous catheter occlusion: a prospective, controlled trial examining the impact of a positive-pressure valve device. JPEN: Journal of Parenteral and Enteral Nutrition 28 (2 113 118.
23. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J.M., Gavaghan D.J. McQuay H.J. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 17 (1 1 12.
24. Kirkpatrick A., Rathbun S., Whitsett T. Raskob G. (2007) Prevention of central venous catheter-associated thrombosis: a meta-analysis. American Journal of Medicine 120 (10 901.e1 901.e13.
25. Kishimoto T.K., Viswanathan K., Ganguly T., Elankumaran S., Smith S., Pelzer K., Lansing J.C., Sriranganathan N., Zhao G., Galcheva-Gargova Z., Al-Hakim A., Bailey G.S., Fraser B., Roy S., Rogers-Cotrone T., Buhse L., Whary M., Fox J., Nasr M., Dal Pan G.J., Shriver Z., Langer R.S., Venkataraman G., Austen K.F., Woodcock J. Sasisekharan R. (2008) Contaminated heparin associated with adverse clinical events and activation of the contact system. New England Journal of Medicine 358 (23 2457 2467. (Pubitemid 351793019)
26. Kuehn B.M. (2008) FDA to boost its presence in China. JAMA 299 (15 1762.
27. Long D.A. Coulthard M.G. (2006) Effect of heparin-bonded central venous catheters on the incidence of catheter-related thrombosis and infection in children and adults. Anaesthesia and Intensive Care 34 (4 481 484.
28. López-Briz E. Ruiz-García V. (2005) Effectiveness of heparin versus NaCl 0.9% in central venous catheter flushing. A systematic review. Farmacia Hospitalaria 29 (4 258 264.
29. Maragakis L.L., Bradley K.L., Song X., Beers C., Miller M.R., Cosgrove S.E. Perl T.M. (2006) Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infection Control and Hospital Epidemiology 27 (1 67 70.
30. Mayo D.J., Horne M.K. III., Summers B.L., Pearson D.C. Helsabeck C.B. (1996) The effects of heparin flush on patency of the Groshong catheter: a pilot study. Oncology Nursing Forum 23 (9 1401 1405.
31. Members of the Central Venous Access Device Guideline Panel (2006) Managing Central Venous Access Devices in Cancer Patients: A Clinical Practice Guideline, Cancer Care Ontario, Toronto.
32. Mermel L.A. (2000) Prevention of intravascular catheter-related infections. Annals of Internal Medicine 132 (5 391 402.
33. Mermel L.A. (2002) Prevention of intravascular catheter-related infections. CINA 18 (9 40 46.
34. O'Grady N.P., Alexander M., Dellinger E.P., Gerberding J.L., Heard S.O., Maki D.G., Masur H., McCormick R.D., Mermel L.A., Pearson M.L., Raad I.I., Randolph A. Weinstein R.A. (2002) Guidelines for the prevention of intravascular catheter-related infections. MMWR Recommendations and Reports 51 (RR-10 1 29.
35. Pellowe C.M., Pratt R.J., Harper P., Loveday H.P., Robinson N., Jones S.R.L.J., MacRae E.D., Mulhall A., Smith G.W., Bray J., Carroll A., Chieveley Williams S., Colpman D., Cooper L., McInnes E., McQuarrie I., Newey J.A., Peters J., Pratelli N., Richardson G., Shah P.J.R., Silk D. Wheatley C., Guideline Development Group (2003) Evidence-based guidelines for preventing healthcare-associated infections in primary and community care in England. The Journal of Hospital Infection 55 (Suppl. 2 S2 S127.
36. Pratt R.J., Pellowe C.M., Wilson J.A., Loveday H.P., Harper P.J., Jones S.R.L.J., McDougall C. Wilcox M.H. (2007) epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. The Journal of Hospital Infection 65 (Suppl. 1 S1 S64.
37. Rabe C., Gramann T., Sons X., Berna M., González-Carmona M.A., Klehr H-U., Sauerbruch T. Caselmann W.H. (2002) Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Medicine 28 (8 1172 1176.
38. Randolph A.G., Cook D.J., Gonzales C.A. Andrew M. (1998a) Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 113 (1 165 171. (Pubitemid 28044941)
39. Randolph A.G., Cook D.J., Gonzales C.A. Andrew M. (1998b) Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials. BMJ 316 (7136 969 975. (Pubitemid 28135145)
40. Ray C.E. Jr., Shenoy S.S., McCarthy P.L., Broderick K.A. Kaufman J.A. (1999) Weekly prophylactic urokinase instillation in tunneled central venous access devices. Journal of Vascular and Interventional Radiology: JVIR 10 (10 1330 1334.
41. Richardson W.S., Wilson M.C., Nishikawa J. Hayward R.S.A. (1995) The well-built clinical question: a key to evidence-based decisions. ACP Journal Club 123 (3 A12 A13.
42. Rummel M.A., Donnelly P.J. Fortenbaugh C.C. (2001) Clinical evaluation of a positive pressure device to prevent central venous catheter occlusion: results of a pilot study. Clinical Journal of Oncology Nursing 5 (6 261 265.
43. Sanchez J.D.A., Battlle J.F. Feijoo J.B. (2007) Catheter-related thrombosis: a critical review. Supportive Cancer Therapy 4 (3 145 151.
44. Schilling S., Doellman D., Hutchinson N. Jacobs B.R. (2006) The impact of needleless connector device design on central venous catheter occlusion in children: a prospective, controlled trial. JPEN: Journal of Parenteral and Enteral Nutrition 30 (2 85 90.
45. Schunemann H.J., Oxman A.D., Brozek J., Glasziou P., Jaeschke R., Vist G.E., Williams J.W. Jr., Kunz R., Craig J., Montori V.M., Bossuyt P. Guyatt G.H. (2008) Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336 (7653 1106 1110. (Pubitemid 351731739)
46. Segars K. (2006) Thromboprophylaxis for central venous catheters in cancer patients. Journal of Gynecologic Oncology Nursing 16 (3 9 17.
47. Solomon B., Moore J., Arthur C. Prince H.M. (2001) Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin. European Journal of Cancer 37 (18 2379 2384.
48. Swanson J.M. (2007) Heparin-induced thrombocytopenia: a general review. Journal of Infusion Nursing 30 (4 232 240.
49. Warkentin T.E. (2007) Heparin-induced thrombocytopenia. Hematology - Oncology Clinics of North America 21 (4 589 607.